Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
IDEX
IEX
$16.3B
| $108M | 0.06% |
718,334
-104,376
| -13% | -$15.6M |
|
377
Magnolia Oil & Gas
MGY
$5.67B
| $108M | 0.06% |
7,198,981
+4,187,082
| +139% | +$54.7M |
|
378
Thor Industries
THO
$4.07B
| $107M | 0.06% |
1,282,906
+21,763
| +2% | +$2.08M |
|
379
PTC
PTC
$14.3B
| $107M | 0.06% |
1,004,358
+14,345
| +1% | +$1.4M |
|
380
Duke Energy
DUK
$101B
| $107M | 0.06% |
1,332,315
+298,533
| +29% | +$24.1M |
|
|
FOLD
381
DELISTED
Amicus Therapeutics
FOLD
| $106M | 0.06% |
8,806,359
+627,972
| +8% | +$8.78M |
|
382
CDW
CDW
$17.6B
| $105M | 0.06% |
1,185,990
+130,139
| +12% | +$11.3M |
|
383
Sally Beauty Holdings
SBH
$1.44B
| $105M | 0.06% |
5,715,122
-1,150,828
| -17% | -$18.4M |
|
384
DTE Energy
DTE
$30.9B
| $105M | 0.06% |
1,128,635
-316,594
| -22% | -$29.5M |
|
385
Manulife Financial
MFC
$73.2B
| $105M | 0.06% |
5,862,471
+2,263,264
| +63% | +$41.1M |
|
386
Webster Financial
WBS
$12.5B
| $105M | 0.06% |
1,776,600
-82,047
| -4% | -$5.34M |
|
|
XEC
387
DELISTED
CIMAREX ENERGY CO
XEC
| $104M | 0.06% |
1,116,391
-2,861
| -0.3% | -$263K |
|
388
Trimble
TRMB
$12.8B
| $104M | 0.06% |
2,384,316
+1,121,373
| +89% | +$43.8M |
|
|
OPLN
389
Openlane
OPLN
$4.21B
| $103M | 0.06% |
4,572,853
+40,156
| +0.9% | +$927K |
|
|
GWPH
390
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $103M | 0.05% |
593,495
-93,460
| -14% | -$13.5M |
|
391
Sun Communities
SUI
$15B
| $102M | 0.05% |
1,006,081
+233,810
| +30% | +$23.3M |
|
392
Madison Square Garden
MSGS
$9.57B
| $102M | 0.05% |
453,436
+3,753
| +0.8% | +$833K |
|
|
MRO
393
DELISTED
Marathon Oil Corporation
MRO
| $102M | 0.05% |
4,373,712
+2,823,849
| +182% | +$59.1M |
|
|
TFCFA
394
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $101M | 0.05% |
2,180,148
+917,847
| +73% | +$42.1M |
|
395
First Horizon
FHN
$12.2B
| $101M | 0.05% |
5,844,951
-10,479
| -0.2% | -$189K |
|
|
MCRN
396
DELISTED
Milacron Holdings Corp.
MCRN
| $101M | 0.05% |
4,968,918
+471,245
| +10% | +$9.55M |
|
397
O'Reilly Automotive
ORLY
$75B
| $99.7M | 0.05% |
4,303,800
-200,235
| -4% | -$4.26M |
|
398
Vertex Pharmaceuticals
VRTX
$123B
| $99.1M | 0.05% |
514,367
-300,420
| -37% | -$53.5M |
|
399
Fortinet
FTNT
$113B
| $99.1M | 0.05% |
5,368,205
+2,310,880
| +76% | +$35.3M |
|
400
Enterprise Products Partners
EPD
$82.7B
| $98.8M | 0.05% |
3,438,609
+56,061
| +2% | +$1.62M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.